Le Lézard
Classified in: Health, Science and technology, Business
Subject: BOARD OF DIRECTORS

Assure Holdings Appoints Scott Page as an Advisor to the Board of Directors


DENVER, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Scott Page as an advisor to the Company's board of directors.

Page brings over 38 years of commercial banking experience to Assure. Currently, he is president of Lobo Consulting, which provides a variety of consulting services to small and mid-sized companies, including debt and capital structuring, strategic planning and executive coaching. Prior to Lobo Consulting, he served as CEO of CoBiz Bank, a wholly owned subsidiary of CoBiz Financial, which is a $3.8 billion financial services company operating in Colorado and Arizona. CoBiz Financial was recently acquired by BOK Financial.

As CEO of CoBiz Bank, Page was responsible for overseeing credit quality, leadership development and the bank's overall strategic direction for growth. During his tenure, he implemented a robust sales organization that drove an annualized growth in loans and deposits of over 10%. Page also served on the board of directors for CoBiz, which included serving as the chairman of the loan committee.

"As we continue to strengthen our board and management team, Scott's extensive background in commercial banking and developing strategies to drive growth will be a valuable resource for our company," said John Farlinger, executive chairman and interim CEO of Assure. "We look forward to utilizing his expertise in corporate finance and strategic planning as we remain committed to scaling our platform and expanding into new markets."

Commenting on his appointment, Page stated, "Assure has built an exceptional neuromonitoring platform that has gained a notable reputation. With the company continuing its expansion efforts into new markets and verticals, I look forward to leveraging my previous banking experience to help the board evaluate the company's capital and debt structure and provide advice regarding management of the company's growth."

Page currently serves on the board of IQ Wired, an innovative telecommunications consulting firm. He holds a Master of Business Administration from the University of New Mexico and is a graduate of the University of Colorado School of Banking.

About Assure Holdings

Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. While Assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. For more information, visit the company's website at www.assureneuromonitoring.com.

Forward-Looking Statements

This news release contains certain statements that may constitute forward-looking information under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance or achievements that Assure anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information. Such information may involve, but is not limited to, comments with respect to strategies, expectations, planned operations and future actions of the Company. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the forgoing) be taken, occur, be achieved, or come to pass.  Forward-looking information is based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of Assure to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors may be based on information currently available to Assure, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs regarding future growth, results of operations, future capital (including the amount, nature and sources of funding thereof) and expenditures. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement.

Investors are cautioned that, except as disclosed in the Filing Statement any information released or received with respect to the reverse take-over may not be accurate or complete and should not be relied upon. Trading in the securities of the Corporation should be considered highly speculative.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities of the Corporation have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Contact

John Farlinger, Executive Chairman
Assure Holdings Corp.
1-604-763-7565
[email protected]

Cody Slach, Managing Director
Liolios Investor Relations
1-949-574-3860
[email protected]


These press releases may also interest you

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

at 07:05
Gilead Sciences, Inc. and Xilio Therapeutics, Inc. today announced an exclusive license agreement to develop and commercialize Xilio's Phase 1 tumor-activated IL-12 program, XTX301. Xilio Therapeutics is a clinical-stage biotechnology company...

at 07:02
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency (DARPA) to achieve DARPA's...

at 07:01
101 Mobility, a leading provider of mobility and accessibility solutions, is thrilled to announce the return of Chris Diehl to its Home Office Team. Chris rejoins 101 Mobility in the role of Director of National Accounts, where he will focus on...



News published on and distributed by: